Welcome to our dedicated page for LEGATO MERGER III SEC filings (Ticker: LEGT), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Legato Merger Corp. III’s SEC docket is less about day-to-day revenue and more about critical milestones—trust-account balances, sponsor warrant moves, and that all-important merger vote. For many investors, decoding a 250-page proxy or piecing together Form 8-K updates on extensions is painful. Stock Titan’s AI-powered summaries turn those dense documents into clear, actionable insights within minutes.
Need the latest Legato Merger Corp. III insider trading Form 4 transactions before redemption deadlines? Our platform streams each filing the moment EDGAR releases it and highlights any executive stock transactions Form 4. Wondering how cash per share in the trust changed? The quarterly earnings report 10-Q filing is parsed automatically, with plain-English explanations of investment income and potential redemptions. Even first-time SPAC watchers can move from “What does Item 1.01 mean?” to understanding Legato Merger Corp. III SEC documents with AI in a single click.
Here’s what you’ll uncover:
- Real-time alerts on Legato Merger Corp. III Form 4 insider transactions and warrant exercises
- AI-driven breakdowns of 8-K material events explained—LOIs, extension votes, PIPE financings
- A concise view of the annual report 10-K simplified—trust investments, risk factors, sponsor fees
- Side-by-side comparisons of each quarterly filing for earnings report filing analysis, even when revenue is zero
- Proxy statement executive compensation details that show how promoters get paid if a deal closes
Stop scrolling through legal jargon. Our expert analysis and AI summaries reveal the pieces that move LEGT’s share price, letting you concentrate on strategy rather than paperwork.
Morgan Stanley Finance LLC (ticker: MS) has filed Amendment No. 1 to Pricing Supplement No. 8,667 for a $440,000 follow-on issuance of Dual Directional Buffered PLUS notes (CUSIP 61778KD61) that will be consolidated with the original $310,000 tranche, bringing the total outstanding to $750,000. The five-year structured notes, due 28 Jun 2030, are unsecured and fully guaranteed by Morgan Stanley.
Key economic terms
- Issue price: $1,000; minimum denomination $1,000.
- Estimated value on pricing date: $943.80 (reflecting structuring & hedging costs).
- Underlying indices: DJIA (INDU 42,982.43), Nasdaq-100 (NDX 22,237.74) and Russell 2000 (RTY 2,136.185).
- Leverage factor: 140% on any positive performance of the worst-performing index.
- Absolute return participation: 100% of any decline up to 20%, effectively capping gain from this feature at 20%.
- Buffer: 20% downside protection; losses begin once the worst performing index falls below 80% of its initial level.
- Minimum maturity payment: 20% of principal.
- No periodic coupons; payment occurs only at maturity.
Cash-flow profile
- Upside scenario: final level > initial level → principal plus 1.4× index appreciation.
- Moderate downside: final level between 80% and 100% of initial → principal plus up to 20% gain.
- Severe downside: final level < 80% of initial → 1:1 loss beyond buffer, floor at 20% of principal.
Placement economics: Investors pay a 3.5% sales commission ($35 per note); net proceeds to Morgan Stanley are $965 per note. The notes will not be listed, and secondary liquidity depends solely on MS & Co., which may discontinue market making at any time.
Risk highlights
- Principal at risk; no interim interest.
- Performance driven solely by the worst performing index, eliminating diversification benefits.
- Credit exposure to Morgan Stanley; notes rank pari passu with other unsecured obligations.
- Estimated value below issue price indicates negative carry at inception.
- Tax treatment uncertain; counsel views notes as prepaid financial contracts, but IRS may disagree.
Strategic context: At $0.75 million aggregate size, the issuance is immaterial to Morgan Stanley’s capital structure but offers the bank low-cost funding while transferring market risk to investors.